BNP Paribas Asset Management
PAHC icon

BNP Paribas Asset Management’s Phibro Animal Health PAHC Stock Holding History

BNP Paribas Asset Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6K Sell
529
-50
-9% -$2.11K ﹤0.01% 2099
2026
Q1 		$32K Buy
579
+146
+34% +$6.95K ﹤0.01% 1884
2025
Q4 		$16K Buy
433
+77
+22% +$3.13K ﹤0.01% 2017
2025
Q3 		$14K Sell
356
-26
-7% -$859 ﹤0.01% 1527
2025
Q2 		$10K Buy
+382
New +$8.33K ﹤0.01% 1778

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BNP Paribas Asset Management's PAHC Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Phibro Animal Health (PAHC) stake by 8.6% in Q2 2026, selling an estimated $2.11K and leaving 529 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2099.

BNP Paribas Asset Management first reported a position in PAHC in Q2 2025 and has held it in 5 quarters since. The position peaked at $32K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • BNP Paribas Asset Management held 529 shares of Phibro Animal Health worth $16.6K as of Q2 2026.
  • BNP Paribas Asset Management sold 50 Phibro Animal Health shares in Q2 2026, an estimated $2.11K.
  • Phibro Animal Health made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2099 holding.
  • BNP Paribas Asset Management first reported a position in Phibro Animal Health in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Phibro Animal Health position peaked at $32K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.